Abstract
Accomplishments of this program have provided numerous dividends and might benefit areas outside infectious diseases.
Highlights
Surveillance and Evaluation of Emerging InfectionsConsensus—for the network as a whole and in each project area. If one considers the distribution of interests and authorities, this model has proven productive
Roots The concepts of emerging infectious diseases are familiar to the scientific community and the public
Active surveillance and related research conducted through collaborations between Centers for Disease Control and Prevention (CDC) and health departments generated information on the burden of and risk factors for toxic shock syndrome, listeriosis, Haemophilus influenzae type b (Hib) and group B Streptococcus (GBS) infections, and meningococcal disease [3,4,5,6]
Summary
Consensus—for the network as a whole and in each project area. If one considers the distribution of interests and authorities, this model has proven productive. Population-based and laboratory-based surveillance, with collection of diseasecausing isolates linked to epidemiologic information from case reports, forms the foundation of many EIP activities This foundation accurately documents the burden of disease and key characteristics of disease-causing microbes and supports special applied research activities, such as evaluation of vaccine effectiveness and epidemiologic risk factor studies. Limbs and Branches With an established network of sites, governance, and a strategy in place, the main limbs, or programs, of the EIP grew in 4 broad thematic areas: invasive bacterial diseases; foodborne diseases; health care–associated infections; and influenza. Foodborne Diseases Active Surveillance Network The Foodborne Disease Active Surveillance Network (FoodNet), the principal foodborne disease component of the EIP, is a collaborative venture among the 10 EIP sites, the USDA and the FDA This network monitors foodborne disease caused by bacterial and parasitic pathogens (Campylobacter, Cryptosporidium, Cyclospora, Listeria, and Salmonella spp.; Shiga toxin–producing Escherichia coli O157 and non-O157 E. coli; and Shigella, Vibrio, and Yersinia spp.) [12]. Guiding principles for the Emerging Infections Program complied from notes of the meeting of the EIP Steering Group, November 13–14, 1996, United States*
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
